2 research outputs found

    Dietary antioxidants and long-term risk of dementia

    No full text
    Background: The Rotterdam Study previously found that higher dietary intakes of vitamins E and C related to lower risk of dementia and Alzheimer disease (AD) over 6 years of follow-up. Objective: To study consumption of major dietary antioxidants relative to long-term risk of dementia. Design: Population-based prospective cohort study. Setting: The Rotterdam Study in the Netherlands. Participants: A total of 5395 participants, 55 years and older, who were free of dementia and provided dietary information at study baseline. Main Outcome Measures: Incidence of dementia and AD, based on internationally accepted criteria, relative to dietary intake of vitamin E, vitamin C, beta carotene, and flavonoids. Results: During a mean follow-up period of 9.6 years, dementia developed in 465 participants, of whom 365 were diagnosed as having AD. In multivariate models adjusted for age, education, apolipoprotein E ε4 genotype, total energy intake, alcohol intake, smoking habits, body mass index, and supplement use, higher intake of vitamin E at study baseline was associated with lower long-term risk of dementia (P=.02 for trend). Compared with participants in the lowest tertile of vitamin E intake, those in the highest tertile were 25% less likely to develop dementia (hazard ratio, 0.75;95%confidence interval, 0.59-0.95 with adjustment for potential confounders). Dietary intake levels of vitamin C, beta carotene, and flavonoids were not associated with dementia risk after multivariate adjustment (P>.99 for trend for vitamin C and beta carotene and P=.60 for trend for flavonoids). Results were similar when risk for AD was specifically assessed. Conclusion: Higher intake of foods rich in vitamin E may modestly reduce long-term risk of dementia and AD

    Total antioxidant capacity of the diet and major neurologic outcomes in older adults

    No full text
    Objective: To evaluate total antioxidant capacity of the diet, measured by the ferric-reducing antioxidant power (FRAP) assay, in relation to risks of dementia and stroke, as well as key structural brain volumes, in the elderly. Methods: We prospectively studied 5,395 participants in the Rott
    corecore